HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Life Science / Faculty of Advanced Life Science >
Peer-reviewed Journal Articles, etc >

Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis

This item is licensed under:Creative Commons Attribution 4.0 International

Files in This Item:
PO11-7 e0158967.pdf3.74 MBPDFView/Open
Please use this identifier to cite or link to this item:

Title: Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
Authors: Suzuki, Kenji Browse this author
Arumugam, Somasundaram Browse this author
Yokoyama, Junji Browse this author
Kawauchi, Yusuke Browse this author
Honda, Yutaka Browse this author
Sato, Hiroki Browse this author
Aoyagi, Yutaka Browse this author
Terai, Shuji Browse this author
Okazaki, Kazuichi Browse this author
Suzuki, Yasuo Browse this author
Mizumoto, Shuji Browse this author
Sugahara, Kazuyuki Browse this author →KAKEN DB
Atreya, Raja Browse this author
Neurath, Markus F. Browse this author
Watanabe, Kenichi Browse this author
Hashiguchi, Taishi Browse this author
Yoneyama, Hiroyuki Browse this author
Asakura, Hitoshi Browse this author
Issue Date: 13-Jul-2016
Publisher: Public Library of Science
Journal Title: PLOS ONE
Volume: 11
Issue: 7
Start Page: e0158967
Publisher DOI: 10.1371/journal.pone.0158967
PMID: 27410685
Abstract: Induction of mucosal healing (MH) is an important treatment goal in inflammatory bowel disease (IBD). Although the molecular mechanisms underlying MH in IBD is not fully explored, local fibrosis would contribute to interfere mucosal repair. Carbohydrate sulfotransferase 15 (CHST15), which catalyzes sulfation of chondroitin sulfate to produce rare E-disaccharide units, is a novel mediator to create local fibrosis. Here we have used siRNA-based approach of silencing CHST15 in dextran sulfate sodium (DSS) induced colitis in mice, human colon fibroblasts and cancer cell lines. In a DSS-induced acute colitis model, CHST15 siRNA reduced CHST15 mRNA in the colon, serum IL-6, disease activity index (DAI) and accumulation of F4/80+ macrophages and ER-TR7+ fibroblasts, while increased Ki-67+ epithelial cells. In DSS-induced chronic colitis models, CHST15 siRNA reduced CHST15 mRNA in the colon, DAI, alpha-smooth muscle actin+ fibroblasts and collagen deposition, while enhanced MH as evidenced by reduced histological and endoscopic scores. We also found that endoscopic submucosal injection achieved effective pancolonic delivery of CHST15 siRNA in mice. In human CCD-18 Co cells, CHST15 siRNA inhibited the expression of CHST15 mRNA and selectively reduced E-units, a specific product biosynthesized by CHST15, in the culture supernatant. CHST15 siRNA significantly suppressed vimentin in both TGF-ß-stimulated CCD18-Co cells and HCT116 cells while up-regulated BMP7 and E-cadherin in HCT116 cells. The present study demonstrated that blockade CHST15 represses colonic fibrosis and enhances MH partly though reversing EMT pathway, illustrating a novel therapeutic opportunity to refractory and fibrotic lesions in IBD.
Type: article
Appears in Collections:生命科学院・先端生命科学研究院 (Graduate School of Life Science / Faculty of Advanced Life Science) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 菅原 一幸

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 - Hokkaido University